Emory surgical oncologists provide multi-modality evaluation and surgical treatment as part of the Winship Cancer Institute of Emory University, Emory's cross-disciplinary cancer treatment, prevention, and research center and Georgia's only NCI Designated Cancer Center. In 2014, U.S. News & World Report ranked Winship one of the top 25 cancer programs in the nation. The center emphasizes applying the latest research as quickly and responsibly as possible to patient care, giving our surgeons the opportunity to offer ground-breaking treatment to their patients due to their involvement in progressive bench and clinical research.
Dr. Charles Staley has been chief of the division of surgical oncology since 1995. Known for conducting novel clinical trials in gastrointestinal cancers, Dr. Staley specializes in treating cancers of the esophagus, pancreas, stomach, liver, small bowel, and rectum. He has investigated gene therapy for metastatic colon cancer and radiofrequency ablation with intra-arterial chemotherapy for patients with colorectal liver metastases. Currently, he and his colleagues are exploring methods of using nanotechnology to treat and diagnose pancreatic and breast cancer.
Developing innovative approaches for cancer gene therapy is one of the primary focuses of the division's basic science research, while its recent clinical research initiatives have included the compilation of new multi-disciplinary databases tracking patient outcomes in both pancreatic and liver cancer and the development and refinement of laparoscopic inguinal lymph node dissections for melanoma and general urinary cancers.
The surgical oncology training program has developed and standardized significantly over the past several years by broadening the scope and measurability of the general surgery resident's learning experience during rotations. The division also offers a breast cancer fellowship officially approved by the Society of Surgical Oncology.